Cost-effectiveness of a pediatric dengue vaccine

被引：116

作者：

Shepard, DS ^{[1
]}

Suaya, JA ^{[1
]}

Halstead, SB ^{[1
]}

Nathan, MB ^{[1
]}

Gubler, DJ ^{[1
]}

Mahoney, RT ^{[1
]}

Wang, DNC ^{[1
]}

Meltzer, MI ^{[1
]}

机构：

[1] Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02454 USA

来源：

VACCINE | 2004年 / 22卷 / 9-10期

关键词：

dengue; vaccine; vaccination; cost-effectiveness; disability-adjusted life year; DALY; developing countries; cost; Southeast Asia;

D O I：

10.1016/j.vaccine.2003.09.019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To ascertain the economic feasibility of a pediatric tetravalent dengue vaccine, we developed and calibrated a cost-effectiveness model of vaccinating children at 15 months in Southeast (SE) Asia using a societal perspective. We assumed that full immunization would require two doses at prices of US$ 0.50 and US$ 10 per dose in the public and private sectors, respectively. The gross cost per 1000 population (of all ages) of the vaccination program would be US$ 154. Due to projected savings in dengue treatment, the net cost per capita would be only US$ 17 (89% below the gross cost). The cost per disability adjusted life year (DALY) saved by a pediatric vaccine would be US$ 50, making the potential vaccine highly cost-effective. Eventually, vaccination may be able to replace environmental control as a strategy for dengue prevention and be cost saving. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：1275 / 1280

页数：6

共 50 条

[1] COST OF DENGUE AND COST-EFFECTIVENESS OF THE DENGUE VACCINE IN PANAMA
Garcia, L. N.
Cerezo, L.
Blas, A.
Alvarez, S.
Quiroz, N.
Caicedo, Navas A. G.
Lopez, J. G.
Vandeputte, C.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
[2] COST-EFFECTIVENESS OF THE VACCINE AGAINST DENGUE 2014
Castro Rodriguez, R.
Rueda-Gallardo, J. A.
Avella Nino, M. F.
Lopez, J. G.
Caicedo Navas, A. G.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A871 - A872
[3] Dengue dynamics and vaccine cost-effectiveness in Brazil
Durham, David P.
Mbah, Martial L. Ndeffo
Medlock, Jan
Luz, Paula M.
Meyers, Lauren A.
Paltiel, A. David
Galvani, Alison P.
[J]. VACCINE, 2013, 31 (37) : 3957 - 3961
[4] Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines
Shim, Eunha
[J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (05): : 1137 - 1147
[5] COST OF DENGUE ILLNESS AND COST-EFFECTIVENESS OF THE CDY-TDV DENGUE VACCINE IN ECUADOR
Lucio-Romero, R.
Henriquez-Trujillo, A. R.
Bermudez-Gallegos, K.
Tello-Ponce, B.
Caicedo, Navas A. G.
Vandeputte, C.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A416 - A416
[6] COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND
Shen, J.
Kharitonova, E.
Biswal, S.
Sharma, M.
Aballea, S.
Tytula, A.
Zawieja, J.
Towle, P.
Hanley, R.
Rungmaitree, S.
[J]. VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
[7] A THRESHOLD ANALYSIS OF THE COST-EFFECTIVENESS OF A DENGUE VACCINE PROGRAM IN YUCATAN, MEXICO
de Broucker, Gatien
del Campo, Jorge Martin
Constenla, Dagna
[J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 457 - 457
[8] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE
RANGO, N
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02): : 117 - 117
[9] COST-EFFECTIVENESS OF FLU VACCINE
不详
[J]. CONNECTICUT MEDICINE, 1982, 46 (10) : 607 - 607
[10] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE
LEVY, E
[J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1981, 29 (02): : 133 - 153

← 1 2 3 4 5 →